Vydence
Manufacturing · Florida, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
8411 Laurel Fair Cir Ste 100, Tampa, Flo...Phone Number
+55 1633065050Website
www.vydence.comRevenue
$14.4 MillionIndustry
About Vydence
VYDENCE specializes in advanced medical and aesthetic laser technologies, offering a versatile platform with multiple laser and light technology options for various treatment indications. Their flagship products include the ETHEREA-MX and ZYE laser platforms, which are designed to enhance clinical practices and improve patient outcomes. Targeting medical professionals, VYDENCE provides comprehensive training and support to ensure effective use of their systems. The company is recognized for its commitment to evidence-based practices and has a global presence in over 40 countries.Explore more
Vydence Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Vydence
Compare insights from companies similar to Vydence, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Vydence Tech Stack
A closer look at the technologies used by Vydence
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vydence
Sign Up For FreeTo access detailed company insights
VYDENCE specializes in advanced medical and aesthetic laser technologies, offering a versatile platform with multiple laser and light technology options for various treatment indications. Their flagship products include the ETHEREA-MX and ZYE laser platforms, which are designed to enhance clinical practices and improve patient outcomes. Targeting m... Read More
